INDV (Indivior Pharmaceuticals) Inventories, Finished Goods: $0 Mil (As of Mar. 2026)


INDV Indivior Pharmaceuticals Inc INDV
75 GF Score
Price $39.80
GF Value $22.96
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Indivior Pharmaceuticals Inventories, Finished Goods?

Indivior Pharmaceuticals INDV -1.12% 75 Inventories, Finished Goods is $0 Mil as of Mar. 2026. GuruFocus rates INDV with a GF Score™ of 75/100 and a GF Value™ of $22.96 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Indivior Pharmaceuticals's quarterly finished goods declined from Sep. 2025 ($82 Mil) to Dec. 2025 ($75 Mil) and declined from Dec. 2025 ($75 Mil) to Mar. 2026 ($0 Mil).

Indivior Pharmaceuticals's annual finished goods increased from Dec. 2023 ($63 Mil) to Dec. 2024 ($94 Mil) but then declined from Dec. 2024 ($94 Mil) to Dec. 2025 ($75 Mil).

Indivior Pharmaceuticals Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for Indivior Pharmaceuticals's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indivior Pharmaceuticals Inventories, Finished Goods Chart

Indivior Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 33.00 45.00 63.00 94.00 75.00

Indivior Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 82.00 75.00 0.00
INDV
75GF Score
Indivior Pharmaceuticals Inc INDV
Inventories, Finished Goods is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Indivior Pharmaceuticals Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of $0 Mil mean?
Indivior Pharmaceuticals (INDV) has a Inventories, Finished Goods of $0 Mil as of Mar. 2026. Finished goods are inventory items that are complete and ready to be sold. View historical data on Indivior Pharmaceuticals and its competitors.
Is Indivior Pharmaceuticals' Inventories, Finished Goods too high?
Indivior Pharmaceuticals' current Inventories, Finished Goods is $0 Mil. Overall, Indivior Pharmaceuticals has a GF Score™ of 75/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Indivior Pharmaceuticals' Inventories, Finished Goods compare to KNSA and AMRX?
Indivior Pharmaceuticals' Inventories, Finished Goods of $0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Drug Manufacturers company?
A good Inventories, Finished Goods depends on the Drug Manufacturers industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Indivior Pharmaceuticals and its competitors. Indivior Pharmaceuticals's current Inventories, Finished Goods is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indivior Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Indivior Pharmaceuticals (INDV) is currently considered Significantly Overvalued. The stock's GF Value™ is $22.96, compared to a current price of $39.80 — trading 73.3% above its estimated fair value. The current Inventories, Finished Goods is $0 Mil. Indivior Pharmaceuticals' overall GF Score™ is 75/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Indivior Pharmaceuticals (INDV), the current Inventories, Finished Goods is $0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Indivior Pharmaceuticals (INDV) Overvalued in 2026?

Based on GuruFocus' analysis, Indivior Pharmaceuticals stock appears to be overvalued. The current stock price of $39.80 is trading 73.3% above its estimated GF Value™ of $22.96. GuruFocus considers Indivior Pharmaceuticals to be Significantly Overvalued.

Key valuation signals for INDV:

  • Inventories, Finished Goods: $0 Mil
  • GF Value™: $22.96 vs. price of $39.80 (73.3% above fair value)
  • GF Score™: 75/100 with 6 warning signs

No single metric tells the full story. See the INDV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Indivior Pharmaceuticals Business Description

Other Exchanges E7P:Germany
Address 10710 Midlothian Turnpike, Suite 125, North Chesterfield, Richmond, VA, USA, 23235
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).
75GF Score

Get the complete analysis for INDV

Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$39.80
Price
$22.96
GF Value